Date: 2011-02-28
Type of information: R&D agreement
Compound:
Company: Novalix(France)Janssen-Cilag(France)
Therapeutic area:
Type agreement: R&D
Action mechanism:
Disease:
Details: Novalix has entered into a multi-year research services agreement for chemistry with Janssen-Cilag, France, to support its drug discovery efforts. Under the terms, NovAliX scientists will provide distant as well on-site chemistry support, optimally exploiting strong organic synthetic expertise and unique biophysical capabilities, to accelerate the drug discovery process. In addition the operational excellence of NovAliX allows to explore a complete new model by which the respective scientists work side by side for greater efficiency and scientific exchange and therefore promoting the concept of Open Innovation.
Financial terms:
Latest news:
